September 2, 2015
ALAMEDA, Calif. – ESI BIO (esibio.com), the stem cell products division of BioTime, Inc., announced today the release of its most recent technology platform designed to give researchers new standardized in vitro assays with greater physiological relevance and accuracy. The VascuNet™ Pericyte Co-Culture Assay provides a stable, clinically relevant angiogenesis model not currently obtainable with [...]
New XRF Analyzer Designed to Speed and Simplify Metal Chemistry Analysis
September 2, 2015
Managers, operators and quality control personnel in the fabrication, positive material identification and scrap metal industries can now assess the chemical composition of metals with a new analyzer that is smaller and lighter than any x-ray fluorescence (XRF) alloy analyzer on the market today. The Thermo Scientific Niton XL5 analyzer is designed to provide results [...]
Optibrium Appoints Head of North American Operations to Support Growing Demand
September 2, 2015
CAMBRIDGE, UK – Optibrium, a developer of software for small molecule discovery and optimisation, today announced the appointment of Dr Tamsin Mansley in a new role as Head of North American Operations. The appointment marks the opening of Optibrium’s new office in Cambridge, MA, USA and represents the next phase in the company’s expansion plans [...]
September 2, 2015
LA JOLLA, CA - SGI-DNA, a Synthetic Genomics, Inc. company announces the launch of the Gibson Assembly®Site-Directed Mutagenesis Kit which allows researchers to efficiently and accurately perform site-directed mutagenesis on DNA fragments. This kit is the third in SGI-DNA’s Gibson Assembly® portfolio, which empowers life science researchers to substantially increase their ability to build genes, [...]
Exiqon acquires all rights to new prostate cancer biomarkers from Aarhus University Hospital.
September 2, 2015
Copenhagen -- Exiqon A/S (NASDAQ Copenhagen: “EXQ”) today announced that the company has exclusively licensed two sets of validated prostate cancer biomarkers from Aarhus University Hospital, Department of Molecular Medicine (MOMA). Exiqon and MOMA collaborate with the objective to identify and validate new biomarkers that can improve the diagnosis and management of prostate cancer patients. [...]
September 2, 2015
WILMINGTON, Mass. -- Implant Sciences Corporation(OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the appointment of Robert Liscouski to the position of President. Mr. Liscouski, formerly Executive Vice President, will continue to serve on the company's Board of Directors. Dr. Bill McGann [...]
ASD Inc. introduces the next generation FieldSpec 4 spectroradiometer
September 2, 2015
ASD Inc., a PANalytical company and a global leader in highperformance NIR analytical instrumentation and materials analysis solutions, today introduces the next generation of ASD’s FieldSpec line of spectroradiometers, the FieldSpec 4 Hi-Res NG. The FieldSpec 4 Hi-Res NG provides enhanced spectral resolution to support accurate calibration and image classification analysis with the next generation [...]
September 2, 2015
WARRENDALE, Pa. -- TESCAN, the Texas A&M Engineering Experiment Station (TEES) and Texas A&M University announced today that a Nanotechnology Collaboration Agreement has been signed between these organizations. The model of engagement between TEES and TESCAN will streamline research initiatives into applications development and in turn drive an industrial outreach program, while strengthening educational opportunities [...]
Bruker AXS and DECTRIS Announce Supply Agreement for HPC Detector Technology
September 2, 2015
KARLSRUHE, Germany and BADEN, Switzerland –– Bruker AXS and DECTRIS Ltd. today announced an agreement for the supply of Hybrid Photon Counting (HPC) pixel detectors for Bruker’s X-ray diffraction (XRD) business. “We have chosen DECTRIS as a supplier because of its high-performance, reliable, and proven HPC detector technology and high-volume production capacity”, says Frank Burgaezy, [...]
ArcherDX Launches VariantPlex™ p53 Panel for Targeted NGS
September 1, 2015
BOULDER, Colo.-- ArcherDX expands the application of its Anchored Multiplex PCR (AMP™) technology to include DNA variant detection with the Archer™ VariantPlex™ p53 Panel. The panel is a targeted next-generation sequencing (NGS)-based assay to detect germline and somatic mutations of the TP53 gene, which is frequently mutated in cancer. “With complete exon coverage of TP53, [...]
